Cell Counting Market

The report "Cell Counting Market by Product (Instruments (Spectrophotometer, Flow Cytometer, Hematology Analyzers, Cell Counters), Consumables (Media, Reagents, Assays, Microplate)), Application, End User (Pharma & Biotech) - Global Forecast to 2029", global cell counting market is estimated to expand to a value of 16.14 billion in 2029 from USD 11.12 billion in 2024, growing at a CAGR of 7.7%. The market is driving at a faster pace owing to various factors such as launch of technologically advanced instruments and increasing investment in research and development. A significant trend driving market growth is shift from manual to automated cell counting, propelled by the need for greater accuracy, enhanced reproducibility, and improved efficiency in high-throughput workflows. Furthermore, robust government funding for biomedical research, combined with growing private investments, continues to drive innovation and accelerate adoption, specially across developed markets like North America and Europe.

Browse 771 market data Tables and 55 Figures spread through 511 Pages and in-depth TOC on "Cell Counting Market by Product (Instruments (Spectrophotometer, Flow Cytometer, Hematology Analyzers, Cell Counters), Consumables (Media, Reagents, Assays, Microplate)), Application, End User (Pharma & Biotech) - Global Forecast to 2029"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/cell-counting-market-157450728.html

The media, sera and reagents segment is anticipated to grow at significant CAGR during the forecast period

The market is segmented by product into consumables and instruments. The consumables segment is further divided into media, sera and reagents, assay kits, microplates, accessories, and others. Instruments are further divided into spectrophotometers, flow cytometers, hematology analyzers, cell counters, microscopes, and others. The cell counters segment is further segmented into cell counters by mode (automated and manual) and cell counters by technique Fluorescence-Based Cell Counters, Image-Based Cell Counters, Brightfield Cell Counters, and Other Cell Counters. The consumables segment dominated the market in 2023.

Assay kits hold a significant share in the market owing to ready-to-use solutions for cell viability, proliferation, apoptosis, and cytotoxicity analysis, providing researchers with convenience and efficiency.

Cancer research segment dominated the research applications segment in 2023.

The application segment is divided into research applications, medical applications, and bioproduction and quality control. Research applications is further divided into cancer research, immunology research, neurology research, stem cell research and other research applications. Medical applications is further segmented into hematology & complete blood count (CBC), non-invasive prenatal diagnostics, in vitro fertilization, circulating tumor cell detection, and other medical applications. Cancer research dominated the research application segment owing to the increasing focus on immuno-oncology and personalized medicine leading to an increase in demand for advanced cell counting technologies to support studies on cell proliferation, apoptosis, and immune cell profiling.

Academic and research institute segment lead the end users’ segment in 2023.

Based on the end users, the market is segmented into academic & research institutes, hospitals & diagnostics laboratories, pharmaceutical & biotechnology companies and CROs & CDMOS. Academic & research institutes dominated the segment in 2023 and anticipated to grow at a significant CAGR during the forecast period of 2024-2029. Dominance of the segment is attributable advancements in life sciences research, including drug discovery, cancer research, and stem cell studies. However, hospitals &diagnostic laboratories segment is experiencing significant growth due to the increasing demand for cell counting in clinical diagnostics, particularly in hematology, oncology, and infectious disease testing.

North America region dominated the Cell counting market.

The Cell counting market is segmented by region into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America dominated the market due to advanced healthcare infrastructure, substantial investments in biotechnology and pharmaceutical research, and a strong presence of leading academic institutions. US dominated North American region owing to adoption of innovative technologies, robust government funding for research, and the growing focus on precision medicine. Asia-Pacific (APAC) is witnessing rapid growth, fueled by increasing healthcare investments, expanding research capabilities, and the rising prevalence of chronic diseases. Countries like China, India, and Japan are experiencing significant advancements in biotechnology and clinical diagnostics, contributing to the growing demand for cell counting technologies.

The prominent players operating in the cell counting market are Danaher Corporation, Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Merck KGAA, and Bio-Rad Laboratories, Inc., among Others.

Don’t miss out on business opportunities in Cell Counting Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com